constellation brands inc. - STZ

STZ

Close Chg Chg %
239.72 1.16 0.48%

Pre-Market

240.88

+1.16 (0.48%)

Volume: 1.06M

Last Updated:

Nov 21, 2024, 3:59 PM EDT

Company Overview: constellation brands inc. - STZ

STZ Key Data

Open

$240.13

Day Range

238.48 - 241.36

52 Week Range

224.76 - 274.87

Market Cap

$43.52B

Shares Outstanding

181.54M

Public Float

152.08M

Beta

0.89

Rev. Per Employee

N/A

P/E Ratio

77.07

EPS

$3.13

Yield

158.50%

Dividend

$1.01

EX-DIVIDEND DATE

Nov 5, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

1.27M

 

STZ Performance

1 Week
 
1.37%
 
1 Month
 
0.58%
 
3 Months
 
-1.80%
 
1 Year
 
1.00%
 
5 Years
 
32.86%
 

STZ Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 26
Full Ratings ➔

About constellation brands inc. - STZ

Constellation Brands, Inc. engages in the production, marketing, and distribution of beer, wine, and spirits. It operates through the following segments: Beer, Wine and Spirits, Corporate Operations and Other, and Canopy. The Beer segment includes imported and craft beer brands. The Wine and Spirits segment sells wine brands across all categories-table wine, sparkling wine, and dessert wine-and across all price points. The Corporate Operations and Other segment refers to the costs of executive management, corporate development, corporate finance, human resources, internal audit, investor relations, legal, public relations, and information technology. The Canopy segment consists of canopy equity method Investments. The company was founded by Marvin Sands in 1945 and is headquartered in Rochester, NY.

STZ At a Glance

Constellation Brands, Inc.
50 East Broad Street
Rochester, New York 14614
Phone 1-585-678-7100 Revenue 9.96B
Industry Beverages: Alcoholic Net Income 1.73B
Sector Consumer Non-Durables 2024 Sales Growth 5.373%
Fiscal Year-end 02 / 2025 Employees 10,600
View SEC Filings

STZ Valuation

P/E Current 77.073
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 26.466
Price to Sales Ratio 4.589
Price to Book Ratio 4.665
Price to Cash Flow Ratio 16.445
Enterprise Value to EBITDA 16.402
Enterprise Value to Sales 5.867
Total Debt to Enterprise Value 0.215

STZ Efficiency

Revenue/Employee 939,801.887
Income Per Employee 162,962.264
Receivables Turnover 9.22
Total Asset Turnover 0.396

STZ Liquidity

Current Ratio 1.187
Quick Ratio 0.526
Cash Ratio 0.049

STZ Profitability

Gross Margin 49.283
Operating Margin 31.46
Pretax Margin 22.303
Net Margin 17.34
Return on Assets 6.861
Return on Equity 19.028
Return on Total Capital 7.746
Return on Invested Capital 8.40

STZ Capital Structure

Total Debt to Total Equity 128.887
Total Debt to Total Capital 56.31
Total Debt to Total Assets 48.878
Long-Term Debt to Equity 115.67
Long-Term Debt to Total Capital 50.536
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Constellation Brands Inc. - STZ

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
8.61B 8.82B 9.45B 9.96B
Sales Growth
+3.24% +2.42% +7.17% +5.37%
Cost of Goods Sold (COGS) incl D&A
4.14B 4.22B 4.64B 5.05B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
382.40M 424.30M 476.30M 429.20M
Depreciation
377.10M 419.20M 473.10M 427.90M
Amortization of Intangibles
5.30M 5.10M 3.20M 1.30M
COGS Growth
+3.03% +1.92% +9.93% +8.85%
Gross Income
4.47B 4.60B 4.81B 4.91B
Gross Income Growth
+3.43% +2.88% +4.62% +2.02%
Gross Profit Margin
+51.90% +52.14% +50.90% +49.28%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.61B 1.70B 1.82B 1.78B
Research & Development
- - - -
-
Other SG&A
1.61B 1.70B 1.82B 1.78B
SGA Growth
+3.80% +5.17% +7.52% -2.61%
Other Operating Expense
- - - -
-
Unusual Expense
108.90M 605.80M 138.00M 77.20M
EBIT after Unusual Expense
2.75B 2.30B 2.85B 3.06B
Non Operating Income/Expense
175.90M (1.64B) (2.07B) (401.20M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
150.30M (1.64B) (2.04B) (511.80M)
Interest Expense
382.80M 352.20M 397.80M 433.80M
Interest Expense Growth
-10.71% -7.99% +12.95% +9.05%
Gross Interest Expense
414.30M 377.50M 434.30M 497.50M
Interest Capitalized
31.50M 25.30M 36.50M 63.70M
Pretax Income
2.54B 310.40M 383.60M 2.22B
Pretax Income Growth
+369.03% -87.79% +23.58% +479.20%
Pretax Margin
+29.52% +3.52% +4.06% +22.30%
Income Tax
511.10M 309.40M 422.10M 456.60M
Income Tax - Current - Domestic
93.10M 260.70M (38.80M) 169.00M
Income Tax - Current - Foreign
81.60M (36.10M) 253.10M 139.70M
Income Tax - Deferred - Domestic
181.10M (15.60M) 112.50M 8.70M
Income Tax - Deferred - Foreign
155.30M 100.40M 95.30M 139.20M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
150.30M (1.64B) (2.04B) (511.80M)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.03B 1.00M (38.50M) 1.77B
Minority Interest Expense
33.80M 41.40M 32.50M 37.80M
Net Income
2.00B (40.40M) (71.00M) 1.73B
Net Income Growth
+17,032.20% -102.02% -75.74% +2,532.96%
Net Margin Growth
+23.20% -0.46% -0.75% +17.34%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.00B (40.40M) (71.00M) 1.73B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.00B (40.40M) (71.00M) 1.73B
EPS (Basic)
10.4202 -0.2122 -0.3688 9.4235
EPS (Basic) Growth
+16,825.84% -102.04% -73.80% +2,655.18%
Basic Shares Outstanding
191.74M 190.36M 192.54M 183.31M
EPS (Diluted)
9.2154 -0.2122 -0.3688 9.3901
EPS (Diluted) Growth
+14,891.97% -102.30% -73.80% +2,646.12%
Diluted Shares Outstanding
216.81M 190.36M 192.54M 183.96M
EBITDA
3.24B 3.33B 3.47B 3.56B
EBITDA Growth
+1.25% +2.70% +4.12% +2.81%
EBITDA Margin
+37.63% +37.73% +36.66% +35.77%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 292.048
Number of Ratings 26 Current Quarters Estimate 3.32
FY Report Date 11 / 2024 Current Year's Estimate 13.727
Last Quarter’s Earnings 4.32 Median PE on CY Estimate N/A
Year Ago Earnings 12.06 Next Fiscal Year Estimate 15.153
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 17 21 21
Mean Estimate 3.32 2.50 13.73 15.15
High Estimates 3.48 2.59 14.20 15.85
Low Estimate 3.19 2.39 13.60 14.66
Coefficient of Variance 2.41 2.36 0.88 1.58

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 17 17 19
OVERWEIGHT 5 5 2
HOLD 4 4 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Constellation Brands Inc. - STZ

Date Name Shares Transaction Value
Jul 19, 2024 Jose Manuel Madero Garza Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Jennifer M. Daniels Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Judy A. Schmeling Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Judy A. Schmeling Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Jennifer M. Daniels Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Daniel J. McCarthy Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Daniel J. McCarthy Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Ernesto Mariano Hernández Quiroz Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Ernesto Mariano Hernández Quiroz Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Jose Manuel Madero Garza Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Richard E. Sands Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Robert S. Sands Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Robert S. Sands Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 William T. Giles Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 William T. Giles Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Nicholas I. Fink Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Nicholas I. Fink Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Christopher J. Baldwin Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Christopher J. Baldwin Director 503 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 19, 2024 Richard E. Sands Director 734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Constellation Brands Inc. in the News